US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,248.89

+19.721.60%

Number of Gainers:6

Number of Losers:1

Number of Flat:- -

PE:- -

High:1,251.72

Open:1,229.96

Low:1,229.96

Close:1,229.17

Loading ...

Block Trade: Ageas Abb Sale of Shares by Pfizer- Syndicate Have Had Visibility on Indicative Interest in Excess of Size of Deal - Bookrunner

THOMSON REUTERS

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live

Novo Nordisk warns consumers about counterfeit Ozempic injections

Is Pfizer Stock (PFE) Worth Buying After Its Weight Loss Pill Failure?

BTIG highlights some reasons to own Viking shares after danuglipron discontinued

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds?

Viking Seen as Potential Ticket To Get Pfizer Back Into Obesity Game -- Market Talk

JPMorgan says Pfizer news ‘mostly a positive’ for Structure, Viking

Pfizer discontinues GLP-1 pill trial, stock trades flat

Viking, Structure rally after Pfizer halts obesity drug development

Obesity Drugmakers Shares Rise After Pfizer Ends Development of Weight-Loss Pill Danuglipron

Morgan Stanley sees ‘limited reaction’ in Pfizer shares to oral GLP-1 scrapping

Pfizer (PFE) Gets a Hold from J.P. Morgan

Shares of U.S. Listed Obesity Drugmakers Rise After Pfizer to End Development of Its Experimental Weight-Loss Pill

THOMSON REUTERS

Three Stocks That May Be Trading Below Their Estimated Value In April 2025

Simply Wall St.

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Shares of Eli Lilly up 2%, Drug Developer Viking Therapeutics Shares Rise 16.5%

THOMSON REUTERS

Pfizer Shares Slip After Company Scraps Weight-Loss Pill

NOVO NORDISK SHARES SPIKE HIGHER, LAST UP 4.7%; PFIZER ENDS DEVELOPMENT OF WEIGHT-LOSS PILL

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1248.89,"timestamp":1745351999999,"preClose":1229.1708,"halted":0,"volume":59693689,"delay":0,"changeRate":0.016043,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":19.719238,"latestTime":"04-22 16:00:00 EDT","open":1229.9553,"high":1251.7179,"low":1229.9553,"amount":4755238282.523458,"amplitude":0.017705,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.990998,"peRate":34.826857,"turnoverRate":0.005651,"increases":6,"decrements":1,"flats":0,"marketCap":1332454704192,"floatMarketCap":1254704086112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1251.7179,"amplitude":0.017705,"preClose":1229.1708,"low":1229.9553,"pbRate":"9.990998","latestPrice":1248.89,"volume":59693689,"delay":0,"open":1229.9553,"prevYearClose":1305.0607,"prevWeekClose":1251.235,"prevMonthClose":1314.3724,"prevQuarterClose":1314.3724,"fiveDayClose":1208.2393,"twentyDayClose":1377.3098,"sixtyDayClose":1328.9048,"secType":"PLATE","market":"US","turnoverRate":0.005651,"peRate":34.826857,"marketCap":1332454704192,"floatMarketCap":1254704086112,"timestamp":1745351999999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":6,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527192951","title":"Block Trade: Ageas Abb Sale of Shares by Pfizer- Syndicate Have Had Visibility on Indicative Interest in Excess of Size of Deal - Bookrunner","url":"https://stock-news.laohu8.com/highlight/detail?id=2527192951","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527192951?lang=en_us&edition=fundamental","pubTime":"2025-04-14 23:47","pubTimestamp":1744645652,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS1Y6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","BK4585","LU1023059063.AUD","LU1894683264.USD","LU0170899867.USD","LU0225771236.USD","LU1883839398.USD","SGXZ57979304.SGD","LU0985481810.HKD","LU0321505439.SGD","LU0321505868.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","SG9999002224.SGD","BK4581","BK4599","LU0058720904.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4533","LU1066053197.SGD","SG9999001176.SGD","BK4007","SG9999003800.SGD","LU0225284248.USD","LU0234572021.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","SG9999011175.SGD","BK4592","SG9999013999.USD","IE00BBT3K403.USD","LU1894683348.USD","SG9999001176.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU1057294990.SGD","IE0002270589.USD","BK4550","LU0306806265.USD","LU0306807586.USD","PFE","SG9999002232.USD","BK4568","LU0868494617.USD","LU0456855351.SGD","BK4588"],"gpt_icon":0},{"id":"2527194991","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2527194991","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527194991?lang=en_us&edition=fundamental","pubTime":"2025-04-14 23:32","pubTimestamp":1744644777,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising late Monday morning, up 1.19% to 1,327.75 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm BioNTech  and healthcare company Grifols , which climbed 6.1% and 4%. They were followed by networking and telecoms company Ericsson  and pharmaceutical giant Novo Nordisk , which added 3.2% and 2.5%, respectively.The decliners from continental Europe were led by medical device maker Edap  and hotel and accommodation search platform Trivago , which fell 6.3% and 3.3% respectively.From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical firm Adaptimmune Therapeutics , which were rising 4.3% and 1.4% respectively.The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals  and Mereo BioPharma , which lost 5.1% and 3.9% respectively.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDRX","BK4117","BK4568","BK4077","BK4515","AFG","BK7104","ADAP","BK4599","BK4020","BK4554","BK4532","NVO.AU","BK4551","SLN","LU0154236417.USD","LU1093756325.SGD","BK4585","LU1093756168.USD","GRFS","BNTX","BK4535","TRVG","MREO","IE00BZ1G4Q59.USD","BK4139","BK4505","BK4007","BK4107","BK4588","ERIC","IE00BKVL7J92.USD","BK4591","BK4082","EDAP","BK4548"],"gpt_icon":1},{"id":"2527913581","title":"Novo Nordisk warns consumers about counterfeit Ozempic injections","url":"https://stock-news.laohu8.com/highlight/detail?id=2527913581","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527913581?lang=en_us&edition=fundamental","pubTime":"2025-04-14 23:05","pubTimestamp":1744643140,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has become aware of several hundred units of Ozempic injection 1 mg distributed outside the Novo Nordisk authorized supply chain...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-warns-consumers-about-counterfeit-ozempic-injections?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-warns-consumers-about-counterfeit-ozempic-injections?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4599","NVO","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4007","BK4588","BK4532","LU1093756168.USD"],"gpt_icon":0},{"id":"2527191312","title":"Is Pfizer Stock (PFE) Worth Buying After Its Weight Loss Pill Failure?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527191312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527191312?lang=en_us&edition=fundamental","pubTime":"2025-04-14 23:02","pubTimestamp":1744642948,"startTime":"0","endTime":"0","summary":"Pfizer stock was up on Monday despite the company ending development of weight loss pill danuglipron.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/is-pfizer-stock-pfe-worth-buying-after-its-weight-loss-pill-failure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/is-pfizer-stock-pfe-worth-buying-after-its-weight-loss-pill-failure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306807586.USD","BK4592","LU0058720904.USD","LU1894683348.USD","LU0122379950.USD","LU0234572021.USD","LU1066053197.SGD","LU1023059063.AUD","SG9999001176.SGD","SGXZ57979304.SGD","LU1066051498.USD","SG9999002224.SGD","SG9999002232.USD","IE00BLSP4452.SGD","SG9999013999.USD","LU0985481810.HKD","LU0225771236.USD","BK4568","PFE","BK4581","LU1057294990.SGD","IE0002270589.USD","SG9999001176.USD","BK4585","LU0170899867.USD","IE00BBT3K403.USD","LU1883839398.USD","IE00B19Z3581.USD","BK4007","LU0225284248.USD","LU0289739699.SGD","BK4588","LU0456855351.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","IE00BLSP4239.USD","LU0321505868.SGD","SG9999003800.SGD","LU0321505439.SGD","LU0306806265.USD","SG9999011175.SGD","BK4550","BK4533","LU1894683264.USD","IE000M9KFDE8.USD","BK4534","BK4599"],"gpt_icon":0},{"id":"2527191319","title":"BTIG highlights some reasons to own Viking shares after danuglipron discontinued","url":"https://stock-news.laohu8.com/highlight/detail?id=2527191319","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527191319?lang=en_us&edition=fundamental","pubTime":"2025-04-14 23:00","pubTimestamp":1744642815,"startTime":"0","endTime":"0","summary":"BTIG highlights “some of the most compelling reasons” to own Viking Therapeutics (VKTX) after news from Pfizer (PFE) on the latter’s discontinuatio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/btig-highlights-some-reasons-to-own-viking-shares-after-danuglipron-discontinued?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/btig-highlights-some-reasons-to-own-viking-shares-after-danuglipron-discontinued?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","VKTX","LU0321505868.SGD","LU0225284248.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0225771236.USD","BK4534","SG9999003800.SGD","IE0002270589.USD","SG9999013999.USD","LU0122379950.USD","BK4581","BK4585","IE00BLSP4239.USD","LU0306807586.USD","LU1894683264.USD","LU0234572021.USD","SG9999002232.USD","LU0058720904.USD","LU0289739699.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","BK4599","BK4588","BK4007","IE00BBT3K403.USD","BK4568","SGXZ57979304.SGD","SG9999001176.USD","IE00B19Z3581.USD","BK4592","LU0321505439.SGD","LU1066051498.USD","BK4139","LU0306806265.USD","SG9999002224.SGD","LU0868494617.USD","LU0985481810.HKD","LU1883839398.USD","SG9999001176.SGD","LU0170899867.USD","LU1057294990.SGD","LU0456855351.SGD","BK4533"],"gpt_icon":0},{"id":"2527964071","title":"Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2527964071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527964071?lang=en_us&edition=fundamental","pubTime":"2025-04-14 22:35","pubTimestamp":1744641325,"startTime":"0","endTime":"0","summary":"Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to disco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/smaller-obesity-drugmakers-jump-after-pfizer-scraps-weight-loss-pill?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/smaller-obesity-drugmakers-jump-after-pfizer-scraps-weight-loss-pill?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4588","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4139","LU0321505439.SGD","BK4581","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","PFE","SG9999001176.USD","VKTX","IE00BBT3K403.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","LU0058720904.USD","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","SG9999002224.SGD","SG9999002232.USD","LU0306807586.USD","BK4568","GPCR","LU0868494617.USD","BK4533","LU1894683348.USD","LU0321505868.SGD","LU1883839398.USD","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2527199886","title":"Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527199886","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527199886?lang=en_us&edition=fundamental","pubTime":"2025-04-14 22:21","pubTimestamp":1744640475,"startTime":"0","endTime":"0","summary":"We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc.  stands against other best dividend-paying stocks.Dividend-paying stocks have consistently attracted investor interest due to their long-term value. CNBC highlights this by examining the historical performance of the broader market. Between 1960 and 2024, a $10,000 investment in the index would have grown to over $982,000 purely from stock price appreciation, based on data from FactSet and NYU Stern. However, many companies in the index also returned capital to shareholders through dividends. Had an investor reinvested those dividends over the years, the investment would have ballooned to approximately $6.42 million by the beginning of 2025.According to Nuveen, companies that focus on dividend growth tend to possess strong long-term fundamentals and may deliver relatively attractive performance in the year ahead. Historically, fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-inc-pfe-among-best-142115898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999013999.USD","LU1894683264.USD","LU0225771236.USD","LU0321505868.SGD","IE0002270589.USD","BK4581","PFE","LU0058720904.USD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","BK4592","SG9999002224.SGD","SG9999002232.USD","LU0289739699.SGD","LU1023059063.AUD","LU1883839398.USD","IE00BLSP4239.USD","BK4568","LU0306806265.USD","LU1066051498.USD","SG9999003800.SGD","SG9999001176.SGD","LU0225284248.USD","LU0122379950.USD","BK4550","LU1057294990.SGD","LU0868494617.USD","BK4534","IE00B19Z3581.USD","LU1894683348.USD","LU0456855351.SGD","IE00B19Z3B42.SGD","BK4585","LU0321505439.SGD","LU0234572021.USD","SG9999011175.SGD","BK4533","BK4007","BK4599","BK4588","LU0306807586.USD","IE00BBT3K403.USD","SG9999001176.USD","LU1066053197.SGD","LU0985481810.HKD","LU0170899867.USD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2527160156","title":"Viking Seen as Potential Ticket To Get Pfizer Back Into Obesity Game -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2527160156","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527160156?lang=en_us&edition=fundamental","pubTime":"2025-04-14 22:14","pubTimestamp":1744640040,"startTime":"0","endTime":"0","summary":"1014 ET - The danuglipron setback has pushed Pfizer to the sidelines in the booming obesity market, but Viking Therapeutics' VK2735 could get the drugmaker back in the game, say analysts at William Blair. In a note, Andy Hsieh and Alexandra Ramsey say VK2735, in development as a pill and as an injection, could offer Pfizer a rare opportunity to reestablish not only a mere presence in obesity, but also a leading position beyond the current Novo Nordisk/Eli Lilly duopoly. With shares down significantly over the past six months, Viking sports a market cap of around $2.5 billion, but William Blair sees a fair value of $9.2 billion, or about $82 a share. Viking surges 9.7% to $24.43. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","IE00B19Z3B42.SGD","BK4550","BK4581","LU0225771236.USD","LU0225284248.USD","BK4568","LU0058720904.USD","LU0170899867.USD","SGXZ57979304.SGD","BK4599","LU1057294990.SGD","IE00B19Z3581.USD","LU0321505439.SGD","LU1066053197.SGD","LU0306807586.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU1894683264.USD","LU0456855351.SGD","SG9999002232.USD","BK4585","LU1894683348.USD","SG9999003800.SGD","SG9999001176.SGD","LU0985481810.HKD","LU0289739699.SGD","VKTX","BK4534","BK4592","PFE","SG9999002224.SGD","LU0868494617.USD","BK4533","SG9999001176.USD","LU0306806265.USD","IE0002270589.USD","IE00BLSP4452.SGD","BK4139","BK4007","BK4588","SG9999011175.SGD","LU0234572021.USD","IE00BBT3K403.USD","LU0122379950.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU1066051498.USD","SG9999013999.USD"],"gpt_icon":1},{"id":"2527624231","title":"JPMorgan says Pfizer news ‘mostly a positive’ for Structure, Viking","url":"https://stock-news.laohu8.com/highlight/detail?id=2527624231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527624231?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:55","pubTimestamp":1744638945,"startTime":"0","endTime":"0","summary":"JPMorgan says Pfizer’s (PFE) decision to discontinue development of danuglipron, an oral small molecule GLP-1, due to a liver toxicity issue in one...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jpmorgan-says-pfizer-news-mostly-a-positive-for-structure-viking?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jpmorgan-says-pfizer-news-mostly-a-positive-for-structure-viking?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505868.SGD","BK4504","LU0345769631.USD","LU0820561909.HKD","LU0208291251.USD","LU1064131342.USD","LU1496350502.SGD","LU1883839398.USD","IE000M9KFDE8.USD","LU2023250330.USD","LU0211326839.USD","LU2505996681.GBP","LU2237443622.USD","LU2237443978.SGD","LU0203347892.USD","LU0787776722.HKD","LU1629891620.HKD","LU1551013342.USD","BK4599","LU0225771236.USD","LU1023059063.AUD","LU0942090050.USD","LU1974910355.USD","LU0320765489.SGD","SG9999003800.SGD","IE0002270589.USD","BK4588","LU0820562030.AUD","LU0345769128.USD","IE00BDRTCR15.USD","LU0211327993.USD","LU1720051108.HKD","LU2213496289.HKD","PFE","LU2237443549.SGD","LU0306806265.USD","LU2106854487.HKD","LU0456855351.SGD","LU1988902786.USD","BK4207","BK4568","LU1894683264.USD","BK4592","LU0211328371.USD","BK4007","LU0048584097.USD","LU2237443465.HKD","SG9999002224.SGD","LU0149725797.USD","LU0215105999.USD"],"gpt_icon":0},{"id":"2527819568","title":"Pfizer discontinues GLP-1 pill trial, stock trades flat","url":"https://stock-news.laohu8.com/highlight/detail?id=2527819568","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527819568?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:53","pubTimestamp":1744638810,"startTime":"0","endTime":"0","summary":"Pfizer  announced early Monday that it is halting a late-stage trial of its GLP-1 pill candidate, danuglipron, dashing hopes of the company entering the obesity space in the near term.A trial participant in the phase III trial of its once-daily pill experienced \"potential drug-induced liver injury\" that disappeared after the participant stopped the pill, the company said in a statement.Pfizer has been under pressure to find a new blockbuster in its pipeline to fill the expected revenue drop from some of its key drugs going off patent by the end of the decade. That includes its Prevnar 13 vaccine next year and cancer drug Ibrance in 2028. Both brought in a combined $10.8 billion in 2024, with the Prevnar vaccines contributing $6.4 billion.Mizuho healthcare sector expert Jared Holz explained: \"Now without a GLP in its  pipeline, it is now feasible that PFE could look to bring in an asset  should it choose to stay in the weight-loss game to some extent.\". Click here for in-depth analysis ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-discontinues-glp-1-pill-trial-stock-trades-flat-135330797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0321505439.SGD","LU0708995401.HKD","BK4532","LU2237443895.HKD","LLY","LU0203202063.USD","LU0097036916.USD","LU0109391861.USD","LU2491050154.USD","LU0820561909.HKD","GLP","LU0823416689.USD","LU2552382058.USD","LU1868837136.USD","NVO","IE00BK4W5L77.USD","LU2602419157.SGD","BK4550","LU0289739699.SGD","LU0170899867.USD","LU1551013425.SGD","LU2491050071.SGD","BK4581","SG9999014898.SGD","LU0225284248.USD","PFE","LU2491049909.HKD","SG9999017495.SGD","LU2023250504.SGD","LU2063271972.USD","LU1720051017.SGD","LU2471134523.USD","LU1883839398.USD","IE0002270589.USD","LU0354030438.USD","IE00B4R5TH58.HKD","LU0456855351.SGD","IE0009355771.USD","LU2552382132.HKD","SG9999015945.SGD","IE00BLSP4452.SGD","BK4599","IE00BLSP4239.USD","LU1983299246.USD","LU2237443622.USD","LU2237443382.USD","LU2360106947.USD","LU1894683348.USD","LU1868837300.USD","BK4533"],"gpt_icon":1},{"id":"2527621521","title":"Viking, Structure rally after Pfizer halts obesity drug development","url":"https://stock-news.laohu8.com/highlight/detail?id=2527621521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527621521?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:50","pubTimestamp":1744638656,"startTime":"0","endTime":"0","summary":"Shares of Viking Therapeutics (VKTX) are up 13% to $25.17 in early trading while Structure Therapeutics (GPCR) is up 7% to 17.02. Published first o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viking-structure-rally-after-pfizer-halts-obesity-drug-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viking-structure-rally-after-pfizer-halts-obesity-drug-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1066051498.USD","LU1057294990.SGD","IE00BBT3K403.USD","LU0170899867.USD","LU0234572021.USD","LU0306806265.USD","SG9999003800.SGD","VKTX","BK4581","LU0225771236.USD","LU1894683348.USD","IE00B19Z3581.USD","SG9999002224.SGD","LU0058720904.USD","IE0002270589.USD","IE000M9KFDE8.USD","BK4139","LU0321505868.SGD","LU0122379950.USD","LU0321505439.SGD","SG9999001176.USD","LU1883839398.USD","BK4568","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4550","LU0289739699.SGD","LU0868494617.USD","LU0456855351.SGD","LU0306807586.USD","LU0985481810.HKD","SG9999002232.USD","BK4585","IE00BLSP4239.USD","SG9999013999.USD","BK4592","SG9999011175.SGD","SGXZ57979304.SGD","BK4534","GPCR","LU1066053197.SGD","LU1894683264.USD","BK4007","BK4599","IE00BLSP4452.SGD","BK4533","LU0225284248.USD","BK4588","LU1023059063.AUD"],"gpt_icon":0},{"id":"2527137975","title":"Obesity Drugmakers Shares Rise After Pfizer Ends Development of Weight-Loss Pill Danuglipron","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137975","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527137975?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:48","pubTimestamp":1744638490,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ01Z:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Obesity Drugmakers Shares Rise After Pfizer Ends Development of Weight-Loss Pill Danuglipron","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","GPCR","IE00BLSP4452.SGD","LU1066051498.USD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LLY","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","VKTX","LU0868494617.USD","NVO","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU1023059063.AUD","BK4592","LU0058720904.USD","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2527161066","title":"Morgan Stanley sees ‘limited reaction’ in Pfizer shares to oral GLP-1 scrapping","url":"https://stock-news.laohu8.com/highlight/detail?id=2527161066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527161066?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:36","pubTimestamp":1744637805,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Terence Flynn notes that Pfizer (PFE) announced that after a review of the totality of the data for its pipeline oral GLP-1 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/morgan-stanley-sees-limited-reaction-in-pfizer-shares-to-oral-glp-1-scrapping?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/morgan-stanley-sees-limited-reaction-in-pfizer-shares-to-oral-glp-1-scrapping?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0122379950.USD","BK4568","LU1894683264.USD","LU0106831901.USD","LU0985481810.HKD","BK4581","LU1720051108.HKD","IE00BBT3K403.USD","IE0002270589.USD","LU0158827948.USD","BK4127","LU1162221912.USD","LU0158827781.USD","LU2023251221.USD","IE00BZ1G4Q59.USD","SG9999002224.SGD","LU0098860793.USD","LU1989772923.USD","LU0170899867.USD","LU2133065610.SGD","LU1363072403.SGD","LU1720051017.SGD","LU2357305700.SGD","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","LU0006306889.USD","LU0971096721.USD","PFE","IE00BKVL7J92.USD","LU1023059063.AUD","LU2089284900.SGD","MS","BK4590","LU0267386448.USD","GLP","BK4592","LU0058720904.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","LU0314104364.USD","BK4007","BK4599","LU1074936037.SGD","LU0795875169.SGD","BK4144","SG9999003800.SGD","BK4516"],"gpt_icon":0},{"id":"2527161088","title":"Pfizer (PFE) Gets a Hold from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2527161088","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527161088?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:35","pubTimestamp":1744637714,"startTime":"0","endTime":"0","summary":"In a report released today, Chris Schott from J.P. Morgan maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $30.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pfizer-pfe-gets-a-hold-from-j-p-morgan-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pfizer-pfe-gets-a-hold-from-j-p-morgan-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE000M9KFDE8.USD","SG9999003800.SGD","LU0106831901.USD","BK4592","LU0795875169.SGD","LU0289739699.SGD","BK4581","LU1989772923.USD","BK4599","LU2023251221.USD","LU2089284900.SGD","LU1074936037.SGD","LU1548497426.USD","PFE","LU1363072403.SGD","SG9999013999.USD","BK4516","BK4568","LU1023059063.AUD","BK4007","LU2133065610.SGD","IE00BZ1G4Q59.USD","LU1720051108.HKD","LU0321505868.SGD","LU0058720904.USD","LU0971096721.USD","BK4127","IE0002270589.USD","SG9999002224.SGD","LU0306807586.USD","LU2357305700.SGD","LU0006306889.USD","LU0158827948.USD","LU0158827781.USD","LU1894683264.USD","LU0170899867.USD","SG9999011175.SGD","LU0122379950.USD","LU0314104364.USD","LU0098860793.USD","LU1162221912.USD","LU0306806265.USD","SG9999001176.SGD","IE00BKVL7J92.USD","LU1720051017.SGD","LU0267386448.USD","IE00B19Z3B42.SGD","SG9999001176.USD","IE00BBT3K403.USD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2527161153","title":"Shares of U.S. Listed Obesity Drugmakers Rise After Pfizer to End Development of Its Experimental Weight-Loss Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2527161153","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527161153?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:33","pubTimestamp":1744637610,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS20M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1061106388.HKD","LU2552382132.HKD","LU0672654240.SGD","LU1974910355.USD","BK4599","LU1894683264.USD","LU0109391861.USD","LU2237443895.HKD","LU0466842654.USD","IE00BK4W5M84.HKD","LU0106261372.USD","SGXZ31699556.SGD","LU0306806265.USD","LU2089984988.USD","LU0306807586.USD","SG9999011175.SGD","IE00B2B36J28.USD","VKTX","BK4588","SG9999013999.USD","LU1883839398.USD","IE00BLSP4452.SGD","SG9999015945.SGD","LU1814569148.SGD","LU2237443549.SGD","LLY","LU0320765059.SGD","LU2602419157.SGD","IE00BBT3K403.USD","LU2461242641.AUD","LU0417517546.SGD","LU2360106947.USD","LU0882574055.USD","SG9999014914.USD","LU1989771016.USD","LU0321505439.SGD","IE00B4R5TH58.HKD","LU2237443382.USD","IE0002270589.USD","LU0471298777.SGD","LU1066051498.USD","LU0114720955.EUR","SGXZ57979304.SGD","BK4550","IE00BK4W5L77.USD","LU0097036916.USD","LU1280957306.USD","PFE","IE000M9KFDE8.USD","LU2491049909.HKD"],"gpt_icon":0},{"id":"2527154918","title":"Three Stocks That May Be Trading Below Their Estimated Value In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527154918","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527154918?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:37","pubTimestamp":1744630675,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 5.8%, contributing to a 4.8% climb over the past year, with earnings forecasted to grow by 14% annually. In this environment of growth, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on undervalued assets.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Overview: Synopsys, Inc. is a company that provides electronic design automation software products for designing and testing integrated circuits, with a market cap of approximately $65.13 billion.Insights from our recent growth report point to a promising forecast for Synopsys' business outlook.Click to explore a detailed breakdown of our findings in Synopsys' balance sheet health report.GE Vernova, trading at US$321.43, is undervalued compared to its estimated fair value of US$388.84, with","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/three-stocks-may-trading-below-113755565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GEV","LU2063271972.USD","LU0203201768.USD","IE00B1BXHZ80.USD","BK4207","BK4599","LU2237443895.HKD","LU2237443465.HKD","BK4581","LU0823416689.USD","LU2361045086.USD","LU0385154629.USD","LU1303367103.USD","LU2491049909.HKD","LU2491050071.SGD","LU2324357040.USD","FSRL","LU1267930730.SGD","LU1548497426.USD","LU1035775433.USD","IE00BFTCPJ56.SGD","LU1868836591.USD","SG9999018865.SGD","LLY","VIK","SG9999018857.SGD","LU1551013342.USD","SG9999015945.SGD","LU1023059063.AUD","BK4007","BK4182","LU2098885051.SGD","SNPS","LU0124384867.USD","LU0109391861.USD","LU1988902786.USD","NPB","LU0256863902.USD","LU1814569148.SGD","KEY","RC","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2106854487.HKD","SG9999001176.USD","LU0708995401.HKD","LU2471134523.USD","SG9999014906.USD","BK4588","GB00BDT5M118.USD","LU0466842654.USD"],"gpt_icon":1},{"id":"2527533581","title":"Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9","url":"https://stock-news.laohu8.com/highlight/detail?id=2527533581","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527533581?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort VERVE-10","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/14/3060774/0/en/Verve-Therapeutics-Announces-Positive-Initial-Data-from-the-Heart-2-Phase-1b-Clinical-Trial-of-VERVE-102-an-In-Vivo-Base-Editing-Medicine-Targeting-PCSK9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4585","LU1169590202.USD","PD","BK4599","LU1878469433.USD","BK4505","LU1169589451.USD","RNA","BK4539","BK4588","BK4139","VERV","BK4023"],"gpt_icon":0},{"id":"2527213030","title":"Shares of Eli Lilly up 2%, Drug Developer Viking Therapeutics Shares Rise 16.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527213030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527213030?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:54","pubTimestamp":1744628088,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ021:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4592","IE00BLSP4239.USD","LU0320765059.SGD","LU1868836757.USD","LU2491050154.USD","LU2237443978.SGD","LU0061475181.USD","SG9999014914.USD","IE0009355771.USD","LU0882574139.USD","LU0471298694.HKD","LU1548497426.USD","LU2461242641.AUD","LU0640476718.USD","LU0238689110.USD","PFE","LU1868836914.USD","SG9999018865.SGD","VKTX","IE00BBT3K403.USD","LU2264538146.SGD","IE000M9KFDE8.USD","LU1814569148.SGD","LU2360106947.USD","BK4599","IE00B4R5TH58.HKD","IE00BLSP4452.SGD","LU2237443895.HKD","LU2324357040.USD","LU0672654240.SGD","LU1712237335.SGD","LLY","LU1035775433.USD","SG9999017495.SGD","LU0868494617.USD","LU0096364046.USD","LU1093756325.SGD","LU0109391861.USD","BK4533","LU2237443622.USD","GB00BDT5M118.USD","LU1894683348.USD","IE00BK4W5M84.HKD","LU1551013425.SGD","LU0321505868.SGD","LU1883839398.USD","LU2211815571.USD","IE0004445239.USD","BK4516","LU1066053197.SGD"],"gpt_icon":0},{"id":"2527305881","title":"Pfizer Shares Slip After Company Scraps Weight-Loss Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2527305881","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527305881?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:54","pubTimestamp":1744628040,"startTime":"0","endTime":"0","summary":"Pfizer shares moved lower in premarket trading Monday after the drugmaker said it is scrapping its experimental weight-loss pill danuglipron, keeping the company on the sidelines of the booming obesity market.Shares of the New York company, which closed Friday at $21.91, were recently down 1.9% at $21.50 in premarket trading.Pfizer said the move follows a review of the program's clinical data, including the case of a single participant in a dose-optimization study who experienced a potential drug-induced liver injury that resolved after discontinuing danuglipron.Pfizer previously ended a study of a twice-daily version of danuglipron after disappointing trial results in which there were too many side effects.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","BK4599","BK4534","BK4581","BK4592","LU0234572021.USD","LU1057294990.SGD","BK4585","PFE","BK4533","IE00BLSP4239.USD","SG9999002232.USD","LU1883839398.USD","SG9999013999.USD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0306807586.USD","LU0058720904.USD","LU0225284248.USD","LU0321505868.SGD","SG9999011175.SGD","LU0225771236.USD","IE0002270589.USD","LU1894683264.USD","IE00BLSP4452.SGD","BK4568","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU0306806265.USD","LU0122379950.USD","LU1066053197.SGD","SG9999003800.SGD","SG9999001176.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683348.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0321505439.SGD","SG9999002224.SGD","LU0985481810.HKD","BK4588","LU0170899867.USD","BK4550"],"gpt_icon":1},{"id":"2527137029","title":"NOVO NORDISK  SHARES SPIKE HIGHER, LAST UP 4.7%; PFIZER  ENDS DEVELOPMENT OF WEIGHT-LOSS PILL","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527137029?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:52","pubTimestamp":1744627950,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL8N3QS0M0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","PFE","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","BK4588","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","LU0122379950.USD","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":156,"code":"91000000","status":"200"}]}}